Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
BNT162b2 Approved by FDA Experimental Vaccine Jul/11/2022 66 0
mRNA-1273 Emergency use authorization Experimental Vaccine Jul/11/2022 28 1
Ad26.COV2.S Emergency use authorization Experimental Vaccine Jun/22/2022 10 1
Convalescent plasma Emergency use authorization Experimental Antiviral May/16/2022 43 10
ACE2‐Fc Potential treatment - pre-clinical evidence Experimental Antiviral Apr/26/2022 5 0
Baicalin Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021 5 0
Daidzin Potential treatment - theoretical effect Natural product Antiviral Mar/11/2021 2 0
Amentoflavone Potential treatment - theoretical effect Natural product Antiviral Feb/16/2021 4 0
Cynaroside Potential treatment - theoretical effect Natural product Antiviral Feb/16/2021 3 0
Oroxylin A Potential treatment - pre-clinical evidence Natural product Antiviral Feb/15/2021 1 0